BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Nov 21, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics
Indication Target/marker/pathway Summary Licensing status Publication and contact information
Amyotrophic lateral sclerosis (ALS) Chromosome 9 open reading frame 72 (C9orf72) Studies in patient samples and mice suggest antisense oligonucleotides targeting the hexanucleotide repeat in C9orf72 could help treat some patients with ALS. GGGGCC repeats in...

Read the full 341 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >